The Paracetamol Market is poised to grow at a CAGR of 4.3% during the forecast period (2021-2026).
The COVID-19 pandemic is expected to have a significant impact on the market. Paracetamol, due to its widespread availability, has been recommended by vari…
The neuromodulation market is expected to register a CAGR of 11% during the forecast period.
Neuromodulation requires surgical interventions but due to the current COVID-19 scenario, the government postponed elective surgeries and procedures. It accounts…
The pain management market was valued at approximately USD 65,108 million in 2020, and it is expected to witness a revenue of USD 86,505 million in 2026, with a CAGR of 4.85% over the forecast period.
The COVID-19 pandemic has impacted the healthcare sys…